Zoetis Inc. (ZTS) Shares outstanding analysis
- Shares outstanding · latest quarter: Value 413.22M; Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 1 year ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares outstanding · 5 years ago: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
- Shares change · vs previous quarter: Value (m); Formula and calculation Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage..
Shares outstanding analysis
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Shares outstanding · latest quarter | 413.22M | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 1 year ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares outstanding · 5 years ago | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. |
| Shares change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
| Shares count change · vs previous quarter | (m) | Own reported common class count; original count date 2026-07-31. Comparisons require matching class and complete dated split coverage. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current quarter shares | 413.22M shares | |
| Previous quarter shares | (m) |
Shares means common shares outstanding, adjusted to the same split basis for comparison. It is a count, not USD or convertible securities; B means billion shares.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current quarter shares (shares) | Shares count change · vs previous quarter | Shares change (%) · vs previous quarter |
|---|---|---|---|
| 2026-06-30 | 413.22M | (m) | (m) |
| 2026-03-31 | 419.23M | (m) | (m) |
| 2025-12-31 | 422.13M | (m) | (m) |
| 2025-09-30 | 440.69M | (m) | (m) |
| 2025-06-30 | 443.18M | (m) | (m) |
| 2025-03-31 | 445.21M | (m) | (m) |
| 2024-12-31 | 447.79M | (m) | (m) |
| 2024-09-30 | 451.17M | (m) | (m) |
| 2024-06-30 | 453.05M | (m) | (m) |
| 2024-03-31 | 456.30M | (m) | (m) |
| 2023-12-31 | 457.87M | (m) | (m) |
| 2023-09-30 | 459.11M | (m) | (m) |
| 2023-06-30 | 460.32M | (m) | (m) |
| 2023-03-31 | 462.11M | (m) | (m) |
| 2022-12-31 | 463.39M | (m) | (m) |
| 2022-09-30 | 466.07M | (m) | (m) |
| 2022-06-30 | 468.14M | (m) | (m) |
| 2022-03-31 | 470.63M | (m) | (m) |
| 2021-12-31 | 471.97M | (m) | (m) |
| 2021-09-30 | 473.13M | (m) | (m) |
| 2021-06-30 | 473.94M | (m) | (m) |
| 2021-03-31 | 474.77M | (m) | (m) |
| 2020-12-31 | 475.17M | (m) | (m) |
| 2020-09-30 | 475.27M | (m) | (m) |
| 2020-06-30 | 475.14M | (m) | (m) |
| 2020-03-31 | 474.94M | (m) | (m) |
| 2019-12-31 | 474.93M | (m) | (m) |
| 2019-09-30 | 476.30M | (m) | (m) |
| 2019-06-30 | 24.33M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |